Abstract:Malignant glioblastoma, also known as Glioblastoma multiforme (GBM), is one of the most aggressive subtypes, characterized by wide vascularization and complex invasion. The currently available standard care for GBM includes maximal surgical resection, radiotherapy, and chemotherapy. These standard therapeutic procedures are facilitating the treatment by means of prolonging the lifetime. However, these processes cannot prevent tumor recurrence in the future and thereby compromise the patient lifetime. This disease recurrence is accredited to the presence of glioma stem cells (GSCs) that are resistant toward chemo and radiation therapies. GSCs are mainly associated with vascular niches that control GSC self-renewal and survival. Therefore, targeting of GSCs using various nanoparticle-assisted therapeutics may improve the efficacy of the drugs used alone or in combination that may result in progress in patient survival. Nanoparticles have been designed with an aim to selectively deliver the cargo to the target cells and therefore are of considerable interest for use in cancer stem cell (CSC) directed anticancer therapies. The structure and properties of nanomaterials influencing the propagation and differentiation of stem cells have been extensively studied and have become a cutting-edge research domain in material science and regenerative medicines. However, due to tumor microenvironment heterogeneity and interpatient variability, these nanoparticles have yielded few clinical outcomes. Despite the formidable challenges, stem cell nanotechnology presents opportunities that can significantly enhance our grasp of stem cell fate and enable the development of groundbreaking stem cell therapies. In doing so, nanoparticle-based stem cell therapy has risen as a promising therapeutic armamentarium to make substantial contributions to the effective treatment of glioblastoma.

Nanotechnology Meets Stem Cell Therapy for Treating Glioblastomas: A Review

Nanomedicines Targeting Glioma Stem Cells

Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy

Targeted Nanotechnology in Glioblastoma Multiforme

Potential of Nanocarrier-Associated Approaches for Better Therapeutic Intervention in the Management of Glioblastoma

Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment

Neural Stem Cell-Based Therapies and Glioblastoma Management: Current Evidence and Clinical Challenges

How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature

Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy.

Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment

Contemporary strategies in glioblastoma therapy: Recent developments and innovations

Nanomedicine facilitated cell signaling blockade: difficulties and strategies to overcome glioblastoma

Glioma nanomedicine: Design, fabrication and theranostic application

Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment via nanotechnology

Advances in Nanotechnology-Based Immunotherapy for Glioblastoma

Brain-targeted Nano-architectures for Efficient Drug Delivery and Sensitization in Glioblastoma

Stem-02. Insights Into Stem Cell Therapies For Glioblastoma: A Systematic Review

Nanoparticles: a New Approach to the Diagnosis and Treatment of Cerebral Glial Tumours

Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade

Advances in nanotechnology for the treatment of GBM

Nanotechnology as a new strategy for the diagnosis and treatment of gliomas